Literature DB >> 19506095

Mitochondrial Thioredoxin: novel regulator for NADPH oxidase and angiotensin II-induced hypertension.

Tohru Fukai.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19506095      PMCID： PMC2773168          DOI： 10.1161/HYPERTENSIONAHA.109.134403

Source DB:  PubMed          Journal:  Hypertension        ISSN： 0194-911X            Impact factor:   10.190


× No keyword cloud information.
  12 in total

1.  H(2)O(2)-induced O(2) production by a non-phagocytic NAD(P)H oxidase causes oxidant injury.

Authors:  W G Li; F J Miller; H J Zhang; D R Spitz; L W Oberley; N L Weintraub
Journal:  J Biol Chem       Date:  2001-05-17       Impact factor: 5.157

2.  Role of NAD(P)H oxidase- and mitochondria-derived reactive oxygen species in cardioprotection of ischemic reperfusion injury by angiotensin II.

Authors:  Shoji Kimura; Guo-Xing Zhang; Akira Nishiyama; Takatomi Shokoji; Li Yao; Yu-Yan Fan; Matlubur Rahman; Takeo Suzuki; Hajime Maeta; Youichi Abe
Journal:  Hypertension       Date:  2005-04-11       Impact factor: 10.190

3.  Endothelial-specific expression of mitochondrial thioredoxin improves endothelial cell function and reduces atherosclerotic lesions.

Authors:  Haifeng Zhang; Yan Luo; Wei Zhang; Yun He; Shengchuan Dai; Rong Zhang; Yan Huang; Pascal Bernatchez; Frank J Giordano; Gerald Shadel; William C Sessa; Wang Min
Journal:  Am J Pathol       Date:  2007-03       Impact factor: 4.307

4.  Extension of murine life span by overexpression of catalase targeted to mitochondria.

Authors:  Samuel E Schriner; Nancy J Linford; George M Martin; Piper Treuting; Charles E Ogburn; Mary Emond; Pinar E Coskun; Warren Ladiges; Norman Wolf; Holly Van Remmen; Douglas C Wallace; Peter S Rabinovitch
Journal:  Science       Date:  2005-05-05       Impact factor: 47.728

5.  Thioredoxin-2 inhibits mitochondria-located ASK1-mediated apoptosis in a JNK-independent manner.

Authors:  Rong Zhang; Rafia Al-Lamki; Lanfang Bai; Jeffrey W Streb; Joseph M Miano; John Bradley; Wang Min
Journal:  Circ Res       Date:  2004-04-29       Impact factor: 17.367

6.  Molecular mechanisms of angiotensin II-mediated mitochondrial dysfunction: linking mitochondrial oxidative damage and vascular endothelial dysfunction.

Authors:  Abdulrahman K Doughan; David G Harrison; Sergey I Dikalov
Journal:  Circ Res       Date:  2007-12-20       Impact factor: 17.367

7.  First evidence for a crosstalk between mitochondrial and NADPH oxidase-derived reactive oxygen species in nitroglycerin-triggered vascular dysfunction.

Authors:  Philip Wenzel; Hanke Mollnau; Matthias Oelze; Eberhard Schulz; Jennifer M Dias Wickramanayake; Johanna Müller; Swenja Schuhmacher; Marcus Hortmann; Stephan Baldus; Tommaso Gori; Ralf P Brandes; Thomas Münzel; Andreas Daiber
Journal:  Antioxid Redox Signal       Date:  2008-08       Impact factor: 8.401

8.  Attenuation of angiotensin II-induced vascular dysfunction and hypertension by overexpression of Thioredoxin 2.

Authors:  Julian D Widder; Daniela Fraccarollo; Paolo Galuppo; Jason M Hansen; Dean P Jones; Georg Ertl; Johann Bauersachs
Journal:  Hypertension       Date:  2009-06-08       Impact factor: 10.190

Review 9.  Thioredoxin in vascular biology: role in hypertension.

Authors:  Talin Ebrahimian; Rhian M Touyz
Journal:  Antioxid Redox Signal       Date:  2008-06       Impact factor: 8.401

Review 10.  Angiotensin II, mitochondria, cytoskeletal, and extracellular matrix connections: an integrating viewpoint.

Authors:  Elena Mv de Cavanagh; Marcelo Ferder; Felipe Inserra; Leon Ferder
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-01-16       Impact factor: 4.733
View more
  10 in total

Review 1.  The mitochondrial component of intracrine action.

Authors:  Richard N Re; Julia L Cook
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-07-09       Impact factor: 4.733

Review 2.  Mitochondrial biogenesis in the metabolic syndrome and cardiovascular disease.

Authors:  Jun Ren; Lakshmi Pulakat; Adam Whaley-Connell; James R Sowers
Journal:  J Mol Med (Berl)       Date:  2010-08-20       Impact factor: 4.599

Review 3.  Oxidant Mechanisms in Renal Injury and Disease.

Authors:  Brian B Ratliff; Wasan Abdulmahdi; Rahul Pawar; Michael S Wolin
Journal:  Antioxid Redox Signal       Date:  2016-04-26       Impact factor: 8.401

4.  Angiotensin II-preconditioning is associated with increased PKCε/PKCδ ratio and prosurvival kinases in mitochondria.

Authors:  Rebeca E Nuñez; Sabzali Javadov; Nelson Escobales
Journal:  Clin Exp Pharmacol Physiol       Date:  2017-09-20       Impact factor: 2.557

Review 5.  The role of the thioredoxin/thioredoxin reductase system in the metabolic syndrome: towards a possible prognostic marker?

Authors:  Alexey A Tinkov; Geir Bjørklund; Anatoly V Skalny; Arne Holmgren; Margarita G Skalnaya; Salvatore Chirumbolo; Jan Aaseth
Journal:  Cell Mol Life Sci       Date:  2018-01-11       Impact factor: 9.261

Review 6.  Regulation of endothelial function by mitochondrial reactive oxygen species.

Authors:  Michael E Widlansky; David D Gutterman
Journal:  Antioxid Redox Signal       Date:  2011-04-26       Impact factor: 8.401

Review 7.  Oxidative stress in hypertension: role of the kidney.

Authors:  Magali Araujo; Christopher S Wilcox
Journal:  Antioxid Redox Signal       Date:  2013-04-30       Impact factor: 8.401

8.  Differences in oxidative stress status and expression of MKP-1 in dorsal medulla of transgenic rats with altered brain renin-angiotensin system.

Authors:  Manisha Nautiyal; Prasad V G Katakam; David W Busija; Patricia E Gallagher; E Ann Tallant; Mark C Chappell; Debra I Diz
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2012-08-22       Impact factor: 3.619

Review 9.  The impact of age-related dysregulation of the angiotensin system on mitochondrial redox balance.

Authors:  Ramya Vajapey; David Rini; Jeremy Walston; Peter Abadir
Journal:  Front Physiol       Date:  2014-11-24       Impact factor: 4.566

10.  Oxidative stress as a potential target in acute kidney injury.

Authors:  Anamaria Magdalena Tomsa; Monica Lia Junie; Alexandru Leonard Alexa; Andreea Liana Rachisan; Lorena Ciumarnean
Journal:  PeerJ       Date:  2019-11-13       Impact factor: 2.984
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.